- Citations, last 5 years
- 4 692
- Works, last 5 years
- 425
- h-index
- 145
- Scientists listed
- 0
- Grants since 2016
- 32
Grants received
2025 · research · Pandemic Antiviral Discovery (PAD)
Advancing Broad-Spectrum Antivirals: Salisylamide Optimization and Preclinical Evaluation
Drugs for Neglected Diseases Initiative · funded by Novo Nordisk Fonden
2024–2026 · grant
Improving gender-inclusive access to treatments for neglected diseases in low- and middle-income countries
Drugs for Neglected Diseases Initiative · funded by International Development Research Centre
2024–2027 · grant · Discretionary Award
Developing the first innovative treatments against visceral leishmaniasis
Dr Fabiana Alves · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2024–2028 · grant · Support to Product Development Partnerships on Global Health - 2024-2028.
Support to DNDi to discover, develop, and deliver treatments for the most neglected populations.
Drugs for Neglected Diseases Initiative · funded by Foreign, Commonwealth and Development Office
2023–2026 · research · Global Health
Drugs for Neglected Diseases Initiative - to develop a new treatment for Onchocerciasis
Drugs for Neglected Diseases Initiative · funded by Bill and Melinda Gates Foundation
2023–2027 · research · Global Health
Drugs for Neglected Diseases Initiative - to support the final stage of development and introduction of acoziborole, a new single-dose, oral treatment for sleeping sickness
Drugs for Neglected Diseases Initiative · funded by Bill and Melinda Gates Foundation
2023 · research · PAD - Influenza
Optimized salicylamide derivatives and prodrugs for the treatment of influenza infections
Drugs for Neglected Diseases Initiative · funded by Novo Nordisk Fonden
2023–2025 · grant · Research and development to help end the preventable deaths of women, children and new-borns (EPD).
Drugs for Neglected Diseases initiative (DNDi) 2017-2024
Drugs for Neglected Diseases Initiative · funded by Foreign, Commonwealth and Development Office
2022–2024 · grant · Cross-Remit
21st Century Treatments for Sustainable Elimination of Leishmaniasis – Part 2 (LeishNCE2)
Fabiana Alves · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2022–2024 · research · Innovations Priority Project
21st Century Treatments for Sustainable Elimination of Leishmaniasis – Part 2 (LeishNCE2)
Dr Fabiana Alves · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2021–2025 · research · RIA
Next generation diagnostics and oral treatment for visceral leishmaniasis in Eastern Africa: transforming patient care through innovation.
Fabiana Alves · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2021–2025 · research · RIA
African leishmaniasis: From clinical research to access
Fabiana Alves · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2021–2022 · grant · Global Development
Drugs for Neglected Diseases Initiative - to expand capacity for development of new medicines for LMIC/LIC diseases
Drugs for Neglected Diseases Initiative · funded by Bill and Melinda Gates Foundation
2021–2025 · grant · Therapeutics Accelerator
Development of an investigational new drug from a novel, open-science, orally available small molecule antiviral targeting SARS-CoV-2 main protease
Dr Peter Sjo · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2021–2026 · grant · Epidemics and Global Health Security Research Programme (Epidemics and GHS)
COVID-19 Therapeutic Accelerator - ANTICOV - Testing multiple early treatment options for mild COVID-19 infected patients.
Drugs for Neglected Diseases Initiative · funded by Foreign, Commonwealth and Development Office
2020–2025 · research · RIA
Towards a pediatric indication for children between 1 and 14 years of age for a safe, effective, all-oral single-dose treatment formulation of acoziborole for first and second stage gambiense human African trypanosomiasis (g-HAT)
Sandra Rembry · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2020–2024 · research · CSA
Capacity development to facilitate the delivery and uptake of Fexinidazole for the elimination of Human African Trypanosomiasis.
Florent Mbo · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2020 · research · RIA
Preparation of an open-label, randomized, comparative, adaptive, multi-country study to test the safety and efficacy of new therapeutic strategies against standard of care in mild SARS-CoV-2 patients in resource-constrained settings.
Nathalie Strub-Wourgaft · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2020–2021 · grant · Cross-Remit
Design and implementation of a translational drug development platform for COVID-19 to generate preclinical evidence in support of treatment arms of the ANTICOV clinical trial
Laurent Fraisse · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2020–2025 · research · RIA
Improved flucytosine formulation for the treatment of meningitis in advanced HIV disease
Isabela Ribeiro · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2020–2023 · grant · Therapeutics Accelerator
Design and implementation of a translational drug development platform for COVID-19 to generate preclinical evidence in support of treatment arms of the ANTICOV clinical trial
Dr Laurent Fraisse · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2019–2023 · research · Global Health
Drugs for Neglected Diseases Initiative - to support the final stages of development and introduction of a new single-dose, oral drug treatment for sleeping sickness
Drugs for Neglected Diseases Initiative · funded by Bill and Melinda Gates Foundation
2019–2022 · grant · Innovations
21st Century Treatments for the Sustainable Elimination of Leishmaniasis
Charles Mowbray · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2019–2024 · research · Global Health
Drugs for Neglected Diseases Initiative - to reduce the timelines to elimination of onchocerciasis
Drugs for Neglected Diseases Initiative · funded by Bill and Melinda Gates Foundation
2019–2022 · research · Innovations Priority Project
21st Century Treatments for Sustainable Elimination of Leishmaniasis
Dr Charles E (Charlie) Mowbray · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2018–2019 · award · Drug Resistant Infections
Global Antibiotic Research & Development Partnership
Manica Balasegaram · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2018–2023 · research · RIA
Towards an arsenic-free oral treatment for human African trypanosomiasis due to Tb rhodesiense as a tool for disease elimination
Olaf Valverde Mordt · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2018–2019 · grant · Discretionary award - DRI
Global Antibiotic Research & Development Partnership
Dr Manica Balasegaram · Drugs for Neglected Diseases Initiative · funded by Wellcome Trust
2017–2022 · grant
Alliances for Chagas elimination in Central America
Drugs for Neglected Diseases Initiative · funded by International Development Research Centre
2017–2021 · research · RIA
Towards an adapted, safe, effective combination treatment for African visceral leishmaniasis (Kala Azar) and improved diagnostic tools.
Jorge Alvar · Drugs for Neglected Diseases Initiative · funded by European and Developing Countries Clinical Trials Partnership
2016–2026 · grant · Product Development Research programme (PDPs)
Drugs for Neglected Diseases initiative (DNDi) 2017-2024
Drugs for Neglected Diseases Initiative · funded by Foreign, Commonwealth and Development Office
2014–2025 · research · Global Development|Global Health
Drugs for Neglected Diseases Initiative - to develop much needed new treatments for filarial diseases (onchocerciasis and lymphatic filariasis), human African trypanosomiasis and visceral l...
Drugs for Neglected Diseases Initiative · funded by Bill and Melinda Gates Foundation